Harpoon Therapeutics, Inc. announced that it has appointed Ms. Georgia L. Erbez as Chief Financial Officer. Additionally, the company announced that it has promoted Holger Wesche, PhD, from Senior Vice President, Research to Chief Scientific Officer. Ms. Erbez previously served as Chief Business Officer and Chief Financial Officer of Zosano Pharma from 2016 through 2018.

She also served as Chief Financial Officer and Executive Vice President of Asterias Biotherapeutics and Chief Financial Officer, Secretary and Treasurer of Raptor Pharmaceuticals. Dr. Wesche joined Harpoon Therapeutics in 2015 as Vice President of Research, and has more than 20 years of biotech experience focused on target validation, drug discovery, and drug development in oncology and inflammation. Prior to Amgen, Dr. Wesche held a leadership role in drug discovery and cell signaling research at Tularik.